Non-invasive in vivo imaging of near infrared-labeled transferrin in breast cancer cells and tumors using fluorescence lifetime FRET

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Abe, Ken ^a   Zhao, Lingling ^b   Periasamy, Ammasi ^c   Intes, Xavier ^b   Barroso, Margarida ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; MICE; MICE, NUDE; SPECTROSCOPY, NEAR-INFRARED; TRANSFERRIN;

EID: 84894327005     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080269     Document Type: Article

References (48)

1. Maeda H (2012) Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumorselective drug targeting. Proc Jpn Acad Ser B Phys Biol Sci 88: 53-71.
2. Prabhakar U, Maeda H, Jain RK, Sevick-Muraca EM, Zamboni W, et al. (2013) Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res 73: 2412-2417.
3. Bartlett DW, Su H, Hildebrandt IJ, Weber WA, Davis ME (2007) Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci U S A 104: 15549-15554.
4. Barbet J, Bardies M, Bourgeois M, Chatal JF, Cherel M, et al. (2012) Radiolabeled antibodies for cancer imaging and therapy. Methods Mol Biol 907: 681-697.
5. Dijkers EC, Kosterink JG, Rademaker AP, Perk LR, van Dongen GA, et al. (2009) Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging. J Nucl Med 50: 974-981.
6. Dijkers EC, de Vries EG, Kosterink JG, Brouwers AH, Lub-de Hooge MN (2008) Immunoscintigraphy as potential tool in the clinical evaluation of HER2/neu targeted therapy. Curr Pharm Des 14: 3348-3362.
7. Williams SP (2012) Tissue distribution studies of protein therapeutics using molecular probes: molecular imaging. AAPS J 14: 389-399.
8. Wang LS, Chuang MC, Ho JA (2012) Nanotheranostics-a review of recent publications. Int J Nanomedicine 7: 4679-4695.
9. Zhang Y, Hong H, Cai W (2011) PET tracers based on Zirconium-89. Curr Radiopharm 4: 131-139.
10. van Dongen GA, Poot AJ, Vugts DJ (2012) PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET. Tumour Biol. 33: 607-615.
11. Luck AN, Mason AB (2013) Structure and dynamics of drug carriers and their interaction with cellular receptors: Focus on serum transferrin. Adv. Drug Deliv. Rev. 65: 1012-1019.
12. Daniels TR, Bernabeu E, Rodriguez JA, Patel S, Kozman M, et al. (2012) The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta 1820: 291-317.
13. Yoon DJ, Liu CT, Quinlan DS, Nafisi PM, Kamei DT (2011) Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer. Ann Biomed Eng 39: 1235-1251.
14. Holland JP, Evans MJ, Rice SL, Wongvipat J, Sawyers CL, et al. (2012) Annotating MYC status with 89Zr-transferrin imaging. Nat Med 18: 1586-1591.
15. Vavere AL, Welch MJ (2005) Preparation, biodistribution, and small animal PET of 45Ti-transferrin. J Nucl Med 46: 683-690.
16. Smith TA, Perkins AC, Walton PH (2004) 99mTc-labelled human serum transferrin for tumour imaging: an in vitro and in vivo study of the complex. Nucl Med Commun 25: 387-391.
17. Prost AC, Anakok M, Aurengo A, Salomon JC, Legrand JC, et al. (1990) Tissue distribution of 131I radiolabeled transferrin in the athymic nude mouse: localization of a human colon adenocarcinoma HT-29 xenograft. Int J Rad Appl Instrum B 17: 209-216.
18. Skarlatos S, Yoshikawa T, Pardridge WM (1995) Transport of [125I]transferrin through the rat blood-brain barrier. Brain Res 683: 164-171.
19. Aloj L, Jogoda E, Lang L, Caraco C, Neumann RD, et al. (1999) Targeting of transferrin receptors in nude mice bearing A431 and LS174T xenografts with [18F]holo-transferrin: permeability and receptor dependence. J Nucl Med 40: 1547-1555.
20. Jeong Lee H, Pardridge WM (2000) Drug targeting to the brain using avidinbiotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease). J Drug Target 8: 413-424.
21. Evans MJ, Holland JP, Rice SL, Doran MG, Cheal SM, et al. (2013) Imaging tumor burden in the brain with 89Zr-transferrin. J Nucl Med 54: 90-95.
22. Sun Y, Wallrabe H, Seo SA, Periasamy A (2011) FRET microscopy in 2010: the legacy of Theodor Forster on the 100th anniversary of his birth. Chem-PhysChem 12: 462-474.
23. Wallrabe H, Bonamy G, Periasamy A, Barroso M (2007) Receptor complexes cotransported via polarized endocytic pathways form clusters with distinct organizations. Mol Biol Cell 18: 2226-2243.
24. Wallrabe H, Elangovan M, Burchard A, Periasamy A, Barroso M (2003) Confocal FRET microscopy to measure clustering of ligand-receptor complexes in endocytic membranes. Biophys J 85: 559-571.
25. McGrath N, Barroso M (2008) Quantum dots as fluorescence resonance energy transfer donors in cells. J Biomed Opt 13: 031210.
26. Periasamy A, Wallrabe H, Chen Y, Barroso M (2008) Chapter 22: Quantitation of protein-protein interactions: confocal FRET microscopy. Methods Cell Biol 89: 569-598.
27. Wallrabe H, Chen Y, Periasamy A, Barroso M (2006) Issues in confocal microscopy for quantitative FRET analysis. Microsc Res Tech 69: 196-206.
28. Ntziachristos V, Ripoll J, Wang LV, Weissleder R (2005) Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 23: 313-320.
29. Leblond F, Davis SC, Valdes PA, Pogue BW (2010) Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications. J Photochem Photobiol B 98: 77-94.
30. McGinty J, Stuckey DW, Soloviev VY, Laine R, Wylezinska-Arridge M, et al. (2011) In vivo fluorescence lifetime tomography of a FRET probe expressed in mouse. Biomed Opt Express 2: 1907-1917.
31. Xiong L, Shuhendler AJ, Rao J (2012) Self-luminescing BRET-FRET near-infrared dots for in vivo lymph-node mapping and tumour imaging. Nat Commun 3: 1193.
32. Venugopal V, Chen J, Barroso M, Intes X (2012) Quantitative tomographic imaging of intermolecular FRET in small animals. Biomed Opt Express 3: 3161-3175.
33. Venugopal V, Chen J, Intes X (2010) Development of an optical imaging platform for functional imaging of small animals using wide-field excitation. Biomed Opt Express 1: 143-156.
34. Sun Y, Day RN, Periasamy A (2011) Investigating protein-protein interactions in living cells using fluorescence lifetime imaging microscopy. Nat Protoc 6: 1324-1340.
35. Talati R, Vanderpoel A, Eladdadi A, Anderson K, Abe K, et al. (2013) Automated Selection of Regions of Interest for Intensity-based FRET Analysis of Transferrin Endocytic Trafficking in Normal vs. Cancer Cells. Methods. http://dx.doi.org/10.1016/j.ymeth.2013.08.017.
36. Elangovan M, Wallrabe H, Chen Y, Day RN, Barroso M, et al. (2003) Characterization of one- and two-photon excitation fluorescence resonance energy transfer microscopy. Methods 29: 58-73.
37. Zimet DB, Thevenin BJ, Verkman AS, Shohet SB, Abney JR (1995) Calculation of resonance energy transfer in crowded biological membranes. Biophys J 68: 1592-1603.
38. Kenworthy AK, Edidin M (1998) Distribution of a glycosylphosphatidylinositol-anchored protein at the apical surface of MDCK cells examined at a resolution of <100 A using imaging fluorescence resonance energy transfer. J Cell Biol 142: 69-84.
39. Kenworthy AK, Petranova N, Edidin M (2000) High-resolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol Biol Cell 11: 1645-1655.
40. Zacharias DA (2002) Sticky caveats in an otherwise glowing report: oligomerizing fluorescent proteins and their use in cell biology. Sci STKE 2002: pe23.
41. Wallrabe H, Stanley M, Periasamy A, Barroso M (2003) One- and two-photon fluorescence resonance energy transfer microscopy to establish a clustered distribution of receptor-ligand complexes in endocytic membranes. J Biomed Opt 8: 339-346.
42. Pentcheva T, Edidin M (2001) Clustering of peptide-loaded MHC class I molecules for endoplasmic reticulum export imaged by fluorescence resonance energy transfer. J Immunol 166: 6625-6632.
43. Maxfield FR, McGraw TE (2004) Endocytic recycling. Nat Rev Mol Cell Biol 5: 121-132.
44. Gkouvatsos K, Papanikolaou G, Pantopoulos K (2012) Regulation of iron transport and the role of transferrin. Biochim Biophys Acta 1820: 188-202.
45. Talekar M, Kendall J, Denny W, Garg S (2011) Targeting of nanoparticles in cancer: drug delivery and diagnostics. Anticancer Drugs 22: 949-962.
46. Renz M, Daniels BR, Vamosi G, Arias IM, Lippincott-Schwartz J (2012) Plasticity of the asialoglycoprotein receptor deciphered by ensemble FRET imaging and single-molecule counting PALM imaging. Proc Natl Acad Sci U S A 109: E2989-2997.
47. Chen J, Venugopal V, Intes X (2011) Monte Carlo based method for fluorescence tomographic imaging with lifetime multiplexing using time gates. Biomed Opt Express 2: 871-886.
48. Venugopal V, Chen J, Lesage F, Intes X (2010) Full-field time-resolved fluorescence tomography of small animals. Opt Lett 35: 3189-3191.